Unhealthy food advertising on Costa Rican and Guatemalan television: a comparative study
Health Promotion International · 2023
DOI: 10.1093/heapro/daad028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Promotion International, 2023. Verfasst von Analí Morales-Juárez und 7 weiteren Autor:innen. Beteiligte Einrichtung: INCAP Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala. Hauptthemen laut MEDLINE: Advertising, Food. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: International Development Research Center.
Abstract (Originalsprache)
This study aimed to exhaustively explore the characteristics of food advertising on TV in Guatemala and Costa Rica. The International Network for Food and Obesity Non-Communicable Diseases (NCDs) Research, Monitoring and Action Support (INFORMAS) methodology was applied. In 2016, we recorded 1440 h of video among 10 TV channels. We used the Pan American Health Organization (PAHO) Nutrient Profile (NP) Model to identify ‘critical nutrients’, whose excessive consumption is associated with NCDs. We created a nutritional quality score (0 if the product did not exceed any critical nutrient, 1 if the product exceeded one and 2 if it exceeded ≥2). We classified food ads as permitted (score = 0) and not-permitted (score 1 or 2) for marketing. Persuasive marketing techniques were classified as promotional characters (e.g. Batman), premium offers (e.g. toys), brand benefit claims (e.g. tasty) and health-related claims (e.g. nutritious). In Guatemala, foods that exceeded one critical nutrient were more likely to use persuasive marketing techniques, and in Costa Rica were those with an excess of ≥2 critical nutrients, compared with foods without any excess in critical nutrients [Guatemala: promotional characters (odds ratio, OR = 16.6, 95% confidence interval, CI: 5.8, 47.3), premium offers (OR = 3.4, 95% CI: 1.4, 8.2) and health-related claims (OR = 3.5, 95% CI: 2.2, 5.7); Costa Rica: health-related claims (OR = 4.2, 95% CI: 2.0, 8.5)]. In conclusion, Guatemalan and Costa Rican children are exposed to an overabundance of not-permitted food ads on TV. This justifies implementing national policies to reduce exposure to not-permitted food for marketing, including on TV and other media.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INCAP Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.
- Nutrition and Health Research Center, National Institute of Public Health, Cuernavaca, Mexico.
- School of Public Health, University of Costa Rica, San José, Costa Rica.
- School of Nutrition, University of Costa Rica, San José, Costa Rica.
- Department of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Analí Morales-Juárez, Emma Lucia Cosenza-Quintana
Förderung
- International Development Research Center
Zitieren
APA
Morales-Juárez, A., Monterrubio, E., Cosenza-Quintana, E. L., Zamora, I., Jensen, M. L., Vandevijvere, S., Ramírez-Zea, M., & Kroker-Lobos, M. F. (2023). Unhealthy food advertising on Costa Rican and Guatemalan television: a comparative study. Health Promotion International. https://doi.org/10.1093/heapro/daad028
Vancouver
Morales-Juárez A, Monterrubio E, Cosenza-Quintana EL, Zamora I, Jensen ML, Vandevijvere S, et al. Unhealthy food advertising on Costa Rican and Guatemalan television: a comparative study. Health Promotion International. 2023. doi:10.1093/heapro/daad028
BibTeX
@article{MoralesJurez2023,
author = {Morales-Juárez, Analí and Monterrubio, Eric and Cosenza-Quintana, Emma Lucia and Zamora, Irina and Jensen, Melissa L and Vandevijvere, Stefanie and Ramírez-Zea, Manuel and Kroker-Lobos, Maria Fernanda},
title = {Unhealthy food advertising on Costa Rican and Guatemalan television: a comparative study},
journal = {Health Promotion International},
year = {2023},
doi = {10.1093/heapro/daad028}
}
EUVIMED